Trial intelligence / Profile preview

ESPRIT: Pitavastatin vs Atorvastatin in T2DM

NCT00889226Phase 4Completed

Sponsor
JW Pharmaceutical Corporation
Start
Apr 2008
Primary completion
May 2009
Modality
Small Molecules
01

Overview

A Phase 4 trial of pitavastatin in hypercholesterolemia, sponsored by JW Pharmaceutical Corporation. Started Apr 2008; status: completed.

02

Drugs

pitavastatin
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT00889226.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00889226.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call